The connection between CH and atherosclerosis has been primarily identified for somatic mutations in TET 2 (Tet methylcytosine dioxygenase 2) and JAK 2 (Janus kinase 2) genes. The gene discussed is TET2; the disease is cyclic hematopoiesis.